<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="nihpa"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC3787843/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787843/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology"><meta name="citation_title" content="Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer"><meta name="citation_authors" content="Sarah L. Kerns, Richard Stock, Nelson N. Stone, Seth R. Blacksburg, Lynda Rath, Ana Vega, Laura Fachal, Antonio Gómez-Caamaño, Dirk De Ruysscher, Guido Lammering, Matthew Parliament, Michael Blackshaw, Michael Sia, Jamie Cesaretti, Mitchell Terk, Rosetta Hixson, Barry S. Rosenstein, Harry Ostrer"><meta name="citation_date" content="June 2013"><meta name="citation_issue" content="3"><meta name="citation_volume" content="107"><meta name="citation_firstpage" content="372"><meta name="citation_doi" content="10.1016/j.radonc.2013.05.001"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC3787843/?report=abstract"><meta name="citation_pmid" content="23719583"><meta name="DC.Title" content="Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="NIH Public Access"><meta name="DC.Contributor" content="Sarah L. Kerns"><meta name="DC.Contributor" content="Richard Stock"><meta name="DC.Contributor" content="Nelson N. Stone"><meta name="DC.Contributor" content="Seth R. Blacksburg"><meta name="DC.Contributor" content="Lynda Rath"><meta name="DC.Contributor" content="Ana Vega"><meta name="DC.Contributor" content="Laura Fachal"><meta name="DC.Contributor" content="Antonio Gómez-Caamaño"><meta name="DC.Contributor" content="Dirk De Ruysscher"><meta name="DC.Contributor" content="Guido Lammering"><meta name="DC.Contributor" content="Matthew Parliament"><meta name="DC.Contributor" content="Michael Blackshaw"><meta name="DC.Contributor" content="Michael Sia"><meta name="DC.Contributor" content="Jamie Cesaretti"><meta name="DC.Contributor" content="Mitchell Terk"><meta name="DC.Contributor" content="Rosetta Hixson"><meta name="DC.Contributor" content="Barry S. Rosenstein"><meta name="DC.Contributor" content="Harry Ostrer"><meta name="DC.Date" content="2013 Jun"><meta name="DC.Identifier" content="10.1016/j.radonc.2013.05.001"><meta name="DC.Language" content="en"><meta property="og:title" content="Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer"><meta property="og:type" content="article"><meta property="og:description" content="Rectal bleeding can occur following radiotherapy for prostate cancer and negatively impacts quality of life for cancer survivors. Treatment and clinical factors do not fully predict for rectal bleeding, and genetic factors may be important.A genome-wide ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787843/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><meta name="ncbi_feature" content="associated_data"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-hhspa.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC3787843/epub/"><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC3787843/pdf/nihms487926.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="CE8B98DBDD560AC1000000000102009C.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-ncbiexternallink-4"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3787843%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="pubmed">PubMed</option><option value="books">Books</option><option value="nuccore" class="last">Nucleotide</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox" type="text"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=hhs%20author%20manuscript[filter]" class="navlink">HHS Author Manuscripts</a></li><li class="accid">PMC3787843</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-hhspa.png" alt="Logo of nihpa" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,57,255,75" alt="About Author manuscripts" title="About Author manuscripts" href="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html" ref="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html"><area shape="rect" coords="256,57,500,75" alt="Submit a manuscript" title="Submit a manuscript" href="https://www.nihms.nih.gov/" ref="reftype=publisher&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="0,0,499,74" alt="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" title="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" href="https://www.ncbi.nlm.nih.gov/pmc/about/public-access/" ref="reftype=publisher&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">Radiother Oncol</a></span>. Author manuscript; available in PMC 2014 Jun 1.</div><div></div><div>Published in final edited form as:</div><div style="margin-left:1em"><div class="fm-vol-iss-date"><a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=23719583" target="pmc_ext" ref="reftype=publisher&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access"><span class="cit">Radiother Oncol. 2013 Jun; 107(3): 372–376. </span></a></div><span class="fm-vol-iss-date">Published online 2013 May 26. </span> <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.1016%2Fj.radonc.2013.05.001" target="pmc_ext" ref="reftype=other&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1016/j.radonc.2013.05.001</a></span></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC3787843</span></div><div class="fm-citation-manuscriptid"><span class="fm-citation-ids-label">NIHMSID: </span><span>NIHMS487926</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/23719583">23719583</a></div></div></div></div><h1 class="content-title">Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer<sup><sup><a href="#FN3" rid="FN3" class=" fn">*</a></sup></sup></h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Kerns%20SL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23719583" class="affpopup" co-rid="_co_idm139767453031184" co-class="co-affbox">Sarah L. Kerns</a>, Ph.D., M.P.H.,<sup>1,</sup><sup>2</sup> <a href="/pubmed/?term=Stock%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23719583" class="affpopup" co-rid="_co_idm139767457729616" co-class="co-affbox">Richard Stock</a>, M.D.,<sup>1</sup> <a href="/pubmed/?term=Stone%20NN%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23719583" class="affpopup" co-rid="_co_idm139767459442976" co-class="co-affbox">Nelson N. Stone</a>, M.D.,<sup>1,</sup><sup>3</sup> <a href="/pubmed/?term=Blacksburg%20SR%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23719583" class="affpopup" co-rid="_co_idm139767459440000" co-class="co-affbox">Seth R. Blacksburg</a>, M.D., M.B.A.,<sup>1</sup> <a href="/pubmed/?term=Rath%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23719583" class="affpopup" co-rid="_co_idm139767456587520" co-class="co-affbox">Lynda Rath</a>, B.F.A.,<sup>1</sup> <a href="/pubmed/?term=Vega%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23719583" class="affpopup" co-rid="_co_idm139767456585280" co-class="co-affbox">Ana Vega</a>, Ph.D.,<sup>4</sup> <a href="/pubmed/?term=Fachal%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23719583" class="affpopup" co-rid="_co_idm139767460200912" co-class="co-affbox">Laura Fachal</a>, M.Sc.,<sup>4</sup> <a href="/pubmed/?term=G%26%23x000f3%3Bmez-Caama%26%23x000f1%3Bo%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23719583" class="affpopup" co-rid="_co_idm139767460198672" co-class="co-affbox">Antonio Gómez-Caamaño</a>, M.D.,<sup>5</sup> <a href="/pubmed/?term=De%20Ruysscher%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23719583" class="affpopup" co-rid="_co_idm139767488424624" co-class="co-affbox">Dirk De Ruysscher</a>, M.D., Ph.D.,<sup>6,</sup><sup>7</sup> <a href="/pubmed/?term=Lammering%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23719583" class="affpopup" co-rid="_co_idm139767456524096" co-class="co-affbox">Guido Lammering</a>, M.D., Ph.D.,<sup>7</sup> <a href="/pubmed/?term=Parliament%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23719583" class="affpopup" co-rid="_co_idm139767456521856" co-class="co-affbox">Matthew Parliament</a>, M.D.,<sup>8</sup> <a href="/pubmed/?term=Blackshaw%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23719583" class="affpopup" co-rid="_co_idm139767448396944" co-class="co-affbox">Michael Blackshaw</a>, M.D.,<sup>8</sup> <a href="/pubmed/?term=Sia%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23719583" class="affpopup" co-rid="_co_idm139767448394704" co-class="co-affbox">Michael Sia</a>, M.D.,<sup>9</sup> <a href="/pubmed/?term=Cesaretti%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23719583" class="affpopup" co-rid="_co_idm139767493253216" co-class="co-affbox">Jamie Cesaretti</a>, M.D.,<sup>10</sup> <a href="/pubmed/?term=Terk%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23719583" class="affpopup" co-rid="_co_idm139767493250976" co-class="co-affbox">Mitchell Terk</a>, M.D.,<sup>10</sup> <a href="/pubmed/?term=Hixson%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23719583" class="affpopup" co-rid="_co_idm139767494102304" co-class="co-affbox">Rosetta Hixson</a>, M.D.,<sup>10</sup> <a href="/pubmed/?term=Rosenstein%20BS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23719583" class="affpopup" co-rid="_co_idm139767494100064" co-class="co-affbox">Barry S. Rosenstein</a>, Ph.D.,<sup>1,</sup><sup>11,</sup><sup>12,</sup><sup>**</sup> and  <a href="/pubmed/?term=Ostrer%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23719583" class="affpopup" co-rid="_co_idm139767458492720" co-class="co-affbox">Harry Ostrer</a>, M.D.<sup>2,</sup><sup>13,</sup><sup>**</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm139767453031184"><h3 class="no_margin">Sarah L. Kerns</h3><p><sup>1</sup>Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY</p><p><sup>2</sup>Department of Pathology, Albert Einstein College of Medicine, Bronx, NY</p><div>Find articles by <a href="/pubmed/?term=Kerns%20SL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23719583">Sarah L. Kerns</a></div></div><div id="_co_idm139767457729616"><h3 class="no_margin">Richard Stock</h3><p><sup>1</sup>Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY</p><div>Find articles by <a href="/pubmed/?term=Stock%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23719583">Richard Stock</a></div></div><div id="_co_idm139767459442976"><h3 class="no_margin">Nelson N. Stone</h3><p><sup>1</sup>Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY</p><p><sup>3</sup>Department of Urology, Mount Sinai School of Medicine, New York, NY</p><div>Find articles by <a href="/pubmed/?term=Stone%20NN%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23719583">Nelson N. Stone</a></div></div><div id="_co_idm139767459440000"><h3 class="no_margin">Seth R. Blacksburg</h3><p><sup>1</sup>Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY</p><div>Find articles by <a href="/pubmed/?term=Blacksburg%20SR%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23719583">Seth R. Blacksburg</a></div></div><div id="_co_idm139767456587520"><h3 class="no_margin">Lynda Rath</h3><p><sup>1</sup>Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY</p><div>Find articles by <a href="/pubmed/?term=Rath%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23719583">Lynda Rath</a></div></div><div id="_co_idm139767456585280"><h3 class="no_margin">Ana Vega</h3><p><sup>4</sup>Fundación Pública Galega de Medicina Xenómica-SERGAS, Grupo de Medicina Xenómica-USC, CIBERER, IDIS, Santiago de Compostela, Spain</p><div>Find articles by <a href="/pubmed/?term=Vega%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23719583">Ana Vega</a></div></div><div id="_co_idm139767460200912"><h3 class="no_margin">Laura Fachal</h3><p><sup>4</sup>Fundación Pública Galega de Medicina Xenómica-SERGAS, Grupo de Medicina Xenómica-USC, CIBERER, IDIS, Santiago de Compostela, Spain</p><div>Find articles by <a href="/pubmed/?term=Fachal%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23719583">Laura Fachal</a></div></div><div id="_co_idm139767460198672"><h3 class="no_margin">Antonio Gómez-Caamaño</h3><p><sup>5</sup>Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain</p><div>Find articles by <a href="/pubmed/?term=G%26%23x000f3%3Bmez-Caama%26%23x000f1%3Bo%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23719583">Antonio Gómez-Caamaño</a></div></div><div id="_co_idm139767488424624"><h3 class="no_margin">Dirk De Ruysscher</h3><p><sup>6</sup>Department of Radiation Oncology, University Hospital Leuven, KU Leuven, Belgium</p><p><sup>7</sup>Department of Radiation Oncology (Maastro clinic/GROW), Maastricht University Medical Center, Maastricht, The Netherlands</p><div>Find articles by <a href="/pubmed/?term=De%20Ruysscher%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23719583">Dirk De Ruysscher</a></div></div><div id="_co_idm139767456524096"><h3 class="no_margin">Guido Lammering</h3><p><sup>7</sup>Department of Radiation Oncology (Maastro clinic/GROW), Maastricht University Medical Center, Maastricht, The Netherlands</p><div>Find articles by <a href="/pubmed/?term=Lammering%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23719583">Guido Lammering</a></div></div><div id="_co_idm139767456521856"><h3 class="no_margin">Matthew Parliament</h3><p><sup>8</sup>Division of Radiation Oncology, Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Canada</p><div>Find articles by <a href="/pubmed/?term=Parliament%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23719583">Matthew Parliament</a></div></div><div id="_co_idm139767448396944"><h3 class="no_margin">Michael Blackshaw</h3><p><sup>8</sup>Division of Radiation Oncology, Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Canada</p><div>Find articles by <a href="/pubmed/?term=Blackshaw%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23719583">Michael Blackshaw</a></div></div><div id="_co_idm139767448394704"><h3 class="no_margin">Michael Sia</h3><p><sup>9</sup>Department of Radiation Oncology, Tom Baker Cancer Center, University of Calgary, Calgary, Canada</p><div>Find articles by <a href="/pubmed/?term=Sia%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23719583">Michael Sia</a></div></div><div id="_co_idm139767493253216"><h3 class="no_margin">Jamie Cesaretti</h3><p><sup>10</sup>Florida Radiation Oncology Group, Jacksonville, FL, United States</p><div>Find articles by <a href="/pubmed/?term=Cesaretti%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23719583">Jamie Cesaretti</a></div></div><div id="_co_idm139767493250976"><h3 class="no_margin">Mitchell Terk</h3><p><sup>10</sup>Florida Radiation Oncology Group, Jacksonville, FL, United States</p><div>Find articles by <a href="/pubmed/?term=Terk%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23719583">Mitchell Terk</a></div></div><div id="_co_idm139767494102304"><h3 class="no_margin">Rosetta Hixson</h3><p><sup>10</sup>Florida Radiation Oncology Group, Jacksonville, FL, United States</p><div>Find articles by <a href="/pubmed/?term=Hixson%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23719583">Rosetta Hixson</a></div></div><div id="_co_idm139767494100064"><h3 class="no_margin">Barry S. Rosenstein</h3><p><sup>1</sup>Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY</p><p><sup>11</sup>Department of Radiation Oncology, New York University School of Medicine, New York, NY</p><p><sup>12</sup>Departments of Dermatology and Preventive Medicine, Mount Sinai School of Medicine, New York, NY</p><div>Find articles by <a href="/pubmed/?term=Rosenstein%20BS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23719583">Barry S. Rosenstein</a></div></div><div id="_co_idm139767458492720"><h3 class="no_margin">Harry Ostrer</h3><p><sup>2</sup>Department of Pathology, Albert Einstein College of Medicine, Bronx, NY</p><p><sup>13</sup>Department of Genetics, Albert Einstein College of Medicine, Bronx, NY</p><div>Find articles by <a href="/pubmed/?term=Ostrer%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23719583">Harry Ostrer</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm139767454198224_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm139767454198224_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm139767454198224_ai" style="display:none"><div class="fm-affl" id="A1" lang="en"><sup>1</sup>Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY</div><div class="fm-affl" id="A2" lang="en"><sup>2</sup>Department of Pathology, Albert Einstein College of Medicine, Bronx, NY</div><div class="fm-affl" id="A3" lang="en"><sup>3</sup>Department of Urology, Mount Sinai School of Medicine, New York, NY</div><div class="fm-affl" id="A4" lang="en"><sup>4</sup>Fundación Pública Galega de Medicina Xenómica-SERGAS, Grupo de Medicina Xenómica-USC, CIBERER, IDIS, Santiago de Compostela, Spain</div><div class="fm-affl" id="A5" lang="en"><sup>5</sup>Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain</div><div class="fm-affl" id="A6" lang="en"><sup>6</sup>Department of Radiation Oncology, University Hospital Leuven, KU Leuven, Belgium</div><div class="fm-affl" id="A7" lang="en"><sup>7</sup>Department of Radiation Oncology (Maastro clinic/GROW), Maastricht University Medical Center, Maastricht, The Netherlands</div><div class="fm-affl" id="A8" lang="en"><sup>8</sup>Division of Radiation Oncology, Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Canada</div><div class="fm-affl" id="A9" lang="en"><sup>9</sup>Department of Radiation Oncology, Tom Baker Cancer Center, University of Calgary, Calgary, Canada</div><div class="fm-affl" id="A10" lang="en"><sup>10</sup>Florida Radiation Oncology Group, Jacksonville, FL, United States</div><div class="fm-affl" id="A11" lang="en"><sup>11</sup>Department of Radiation Oncology, New York University School of Medicine, New York, NY</div><div class="fm-affl" id="A12" lang="en"><sup>12</sup>Departments of Dermatology and Preventive Medicine, Mount Sinai School of Medicine, New York, NY</div><div class="fm-affl" id="A13" lang="en"><sup>13</sup>Department of Genetics, Albert Einstein College of Medicine, Bronx, NY</div><div id="FN1">Corresponding author: Barry S. Rosenstein, Ph.D., Department of Radiation Oncology, Box 1236, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029. Tel: 212-241-9408, Fax: 212-996-8927, <a href="mailto:dev@null" data-email="ude.mssm@nietsnesor.yrrab" class="oemail">ude.mssm@nietsnesor.yrrab</a></div><div id="FN2"><sup>**</sup>Equal contributions as senior authors to this manuscript</div></div><div class="fm-article-notes fm-panel half_rhythm"></div><div class="permissions fm-panel half_rhythm hide" id="idm139767454198224_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright notice</a> </div><div><a href="#FN5">Publisher's Disclaimer</a></div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>The publisher's final edited version of this article is available  at <a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=23719583" target="pmc_ext" ref="reftype=publisher&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access">Radiother Oncol</a></div><div>See other articles in PMC that <a href="/pmc/articles/PMC3787843/citedby/">cite</a> the published article.</div></div></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="ui-helper-clearfix" id="ui-ncbiinpagenav-heading-3">Associated Data</h2><dl data-count="4" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>01: </strong>Supplementary Figure 1. Principle components analysis. A. 11 HapMap reference populations. B. HapMap populations with prostate RT patients. Abbreviations: YRI, Yoruban in Ibadan, Nigeria; LWK, Luhya in Webuye, Kenya; MKK, Maasai in Kinyawa, Kenya; ASW; African ancestry in Southwest USA; CEU, Utah residents with Northern and Western European ancestry; TSI, Tuscan in Italy; GIH, Gujarati Indians in Houston, Texas; MEX, Mexican ancestry in Los Angeles, California; CHB, Han Chinese in Beijing, China; CHD, Chinese in Metropolitan Denver, Colorado; JPT, Japanese in Tokyo, Japan.</div><div><a href="/pmc/articles/PMC3787843/bin/NIHMS487926-supplement-01.png" data-ga-action="click_feat_suppl">NIHMS487926-supplement-01.png</a><span style="color:gray"> (117K)</span></div><div class="small guid">GUID:&nbsp;ED18E767-56F7-47B1-AE9F-598D538A8862</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>02: </strong>Supplementary Figure 2. Q-Q plot from logistic regression adjusted for the first five principle components.</div><div><a href="/pmc/articles/PMC3787843/bin/NIHMS487926-supplement-02.tif" data-ga-action="click_feat_suppl">NIHMS487926-supplement-02.tif</a><span style="color:gray"> (1.2M)</span></div><div class="small guid">GUID:&nbsp;85E2952C-A918-4B05-BCA8-BBB0DC35E128</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>03.</strong></div><div><a href="/pmc/articles/PMC3787843/bin/NIHMS487926-supplement-03.doc" data-ga-action="click_feat_suppl">NIHMS487926-supplement-03.doc</a><span style="color:gray"> (50K)</span></div><div class="small guid">GUID:&nbsp;85661540-9178-4CFB-90BA-A3B1BA8B825F</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>04.</strong></div><div><a href="/pmc/articles/PMC3787843/bin/NIHMS487926-supplement-04.docx" data-ga-action="click_feat_suppl">NIHMS487926-supplement-04.docx</a><span style="color:gray"> (12K)</span></div><div class="small guid">GUID:&nbsp;9A86DCEB-48BD-4D85-9B69-7290E8C8F6B5</div></div></dd></dl></div><div id="idm139767456599776" class="tsec sec" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139767456599776title">Abstract</h2><!--article-meta--><div><div id="S1" class="sec sec-first"><h3 id="S1title">Background and Purpose</h3><p id="P2" class="p p-first-last">Rectal bleeding can occur following radiotherapy for prostate cancer and negatively impacts quality of life for cancer survivors. Treatment and clinical factors do not fully predict for rectal bleeding, and genetic factors may be important.</p></div><div id="S2" class="sec"><h3 id="S2title">Materials and Methods</h3><p id="P3" class="p p-first-last">A genome-wide association study (GWAS) was performed to identify SNPs associated with development of late rectal bleeding following radiotherapy for prostate cancer. Logistic regression was used to test association between 614,453 SNPs and rectal bleeding in a discovery cohort (79 cases, 289 controls), and top-ranking SNPs were tested in a replication cohort (108 cases, 673 controls) from four independent sites.</p></div><div id="S3" class="sec"><h3 id="S3title">Results</h3><p id="P4" class="p p-first-last">rs7120482 and rs17630638, which tag a single locus on chromosome 11q14.3, reached genome-wide significance for association with rectal bleeding (combined p-values 5.4×10<sup>−8</sup> and 6.9×10<sup>−7</sup> respectively). Several other SNPs had p-values trending towards genome-wide significance, and a polygenic risk score including these SNPs shows a strong rank-correlation with rectal bleeding (Sommers’ d = 5.0×10<sup>−12</sup> in the replication cohort).</p></div><div id="S4" class="sec sec-last"><h3 id="S4title">Conclusions</h3><p id="P5" class="p p-first-last">This GWAS identified novel genetic markers of rectal bleeding following prostate radiotherapy. These findings could lead to development of a predictive assay to identify patients at risk for this adverse treatment outcome so that dose or treatment modality could be modified.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">radiogenomics, prostate cancer, rectal toxicity, genome-wide association study</span></div></div><div id="S5" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S5title">Introduction</h2><p id="P6" class="p p-first">Prostate cancer is one of the most common cancers in the world, with approximately one million new cases diagnosed per year worldwide [<a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_336455997">1</a>]. Prostate cancer can be successfully treated when detected early, by radiotherapy (brachytherapy or intensity-modulated radiation therapy (IMRT)) and/or surgery, and risk of side effects becomes a deciding factor when choosing among treatment options [<a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_336455988">2</a>]. Even with improvements in precision of radiation delivery, some men experience late adverse effects of radiotherapy for prostate cancer, including rectal bleeding. The incidence of rectal bleeding is dependent, in part, on dosimetry or underlying medical conditions. For example, a multivariate analysis of clinical and patient-specific factors among approximately 780 men treated under the UK Medical Research Council RT01 trial found that prescribed dose and age were significantly associated with risk of rectal toxicity [<a href="#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_336455999">3</a>]. But, variability in dose and demographic factors does not fully explain the variability in rectal bleeding, and prior studies suggest there are underlying genetic risk factors [<a href="#R4" rid="R4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_336455998">4</a>–<a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_336455994">5</a>].</p><p id="P7">Previous studies have investigated associations between SNPs in candidate genes, mainly genes involved in DNA damage response and inflammation, and rectal toxicity in prostate cancer patients treated with radiotherapy [<a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_336455987">6</a>]. However, most of these SNPs have either been investigated in only one study or have shown conflicting results across studies. Few, if any, of these associations have been replicated. A large validation study was recently published in which 92 SNPs in 46 genes were investigated in 637 prostate radiotherapy patients [<a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_336455989">7</a>]. Five rectal endpoints (bleeding, proctitis, sphincter control, stool frequency, tenesmus) were evaluated in patients two years after radiotherapy. None of the previously reported associations for candidate gene SNPs could be confirmed in this project.</p><p id="P8" class="p p-last">In order to take a broader, unbiased approach, we carried out a two-stage GWAS to identify SNPs associated with late rectal bleeding following radiation therapy for prostate cancer.</p></div><div id="S6" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S6title">Materials and Methods</h2><div id="S7" class="sec sec-first"><h3 id="S7title">Patient Characteristics</h3><p id="P9" class="p p-first">The study included men treated with definitive radiation for biopsy proven adenocarcinoma of the prostate (low, intermediate and high risk). Patients were recruited from the Mount Sinai Medical Center in the USA (MSMC), the Clinical University Hospital of Santiago de Compostela in Spain (CHUS), the Maastricht Radiation Oncology Clinic in the Netherlands (MAASTRO), the Cross Cancer Institute and Tom Baker Cancer Centre in Canada (CCI), and the Florida Radiation Oncology Group in the USA (FROG). The MSMC cohort served as a discovery set and the pooled CHUS, MAASTRO, CCI and FROG cohorts served as a replication set. The study was approved by the Institutional Review Boards of the respective study sites, and all men provided informed consent.</p><p id="P10">The MSMC discovery cohort included 764 patients, of which 368 were included in the GWAS (all cases and a randomly selected set of 289 controls). Unselected controls were similar to selected controls with respect to clinical and demographic variables (<a href="/pmc/articles/PMC3787843/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>). Treatment included brachytherapy (206; 56%), brachytherapy with external beam radiation therapy (EBRT) (160; 43.5%), or EBRT alone (2, 0.5%). <sup>125</sup>I (160Gy; TG-43) was used in patients who received brachytherapy alone and <sup>103</sup>Pd (124Gy) in patients who also received EBRT. The EBRT prescription dose was 45Gy in 25 fractions. All implants were performed using a real time ultrasound guided technique previously described [<a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_336455984">8</a>–<a href="#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_336455993">9</a>]. 194 patients (52.7%) received hormonal therapy in addition to radiotherapy.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p7">Patient characteristics for the discovery and replication cohorts. BED, biologically effective dose; Rectum V100, rectal volume receiving 100% of the prescription dose.</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139767453473008" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" valign="top" align="left"></th><th colspan="3" rowspan="1" valign="top" align="center">Discovery Cohort</th><th colspan="2" rowspan="1" valign="top" align="center">Replication Cohort</th></tr><tr><th rowspan="1" colspan="1" valign="bottom" align="left"></th><th rowspan="1" colspan="1" valign="bottom" align="center">Cases=79</th><th rowspan="1" colspan="1" valign="bottom" align="center">Controls=289</th><th rowspan="1" colspan="1" valign="bottom" align="center">Unselected Controls=395</th><th rowspan="1" colspan="1" valign="bottom" align="center">Cases=108</th><th rowspan="1" colspan="1" valign="bottom" align="center">Controls=674</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="left">Age (yrs), mean(sd)</td><td rowspan="1" colspan="1" valign="top" align="center">65 (7.3)</td><td rowspan="1" colspan="1" valign="top" align="center">64 (7.3)</td><td rowspan="1" colspan="1" valign="top" align="center">65 (7.3)</td><td rowspan="1" colspan="1" valign="top" align="center">70 (7.0)</td><td rowspan="1" colspan="1" valign="top" align="center">69 (6.8)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Follow-up (months), mean(sd)</td><td rowspan="1" colspan="1" valign="top" align="center">49.8 (11.0)</td><td rowspan="1" colspan="1" valign="top" align="center">47.6 (12.8)</td><td rowspan="1" colspan="1" valign="top" align="center">46.0 (11.1)</td><td rowspan="1" colspan="1" valign="top" align="center">40 (14.6)</td><td rowspan="1" colspan="1" valign="top" align="center">41 (19.0)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Gleason, N(%)</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> ≤6</td><td rowspan="1" colspan="1" valign="top" align="center">51 (64.6%)</td><td rowspan="1" colspan="1" valign="top" align="center">189 (65.4%)</td><td rowspan="1" colspan="1" valign="top" align="center">231 (58.5%)</td><td rowspan="1" colspan="1" valign="top" align="center">45 (55.6%)</td><td rowspan="1" colspan="1" valign="top" align="center">324 (61.2%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> 7</td><td rowspan="1" colspan="1" valign="top" align="center">23 (29.1%)</td><td rowspan="1" colspan="1" valign="top" align="center">73 (25.3%)</td><td rowspan="1" colspan="1" valign="top" align="center">110 (38.1%)</td><td rowspan="1" colspan="1" valign="top" align="center">23 (28.4%)</td><td rowspan="1" colspan="1" valign="top" align="center">143 (27.0%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> ≥8</td><td rowspan="1" colspan="1" valign="top" align="center">5 (6.3%)</td><td rowspan="1" colspan="1" valign="top" align="center">27 (9.3%)</td><td rowspan="1" colspan="1" valign="top" align="center">54 (13.7%)</td><td rowspan="1" colspan="1" valign="top" align="center">13 (16.0%)</td><td rowspan="1" colspan="1" valign="top" align="center">62 (11.7%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Hormones, N(%)</td><td rowspan="1" colspan="1" valign="top" align="center">42 (53.2%)</td><td rowspan="1" colspan="1" valign="top" align="center">152 (52.6%)</td><td rowspan="1" colspan="1" valign="top" align="center">208 (52.7%)</td><td rowspan="1" colspan="1" valign="top" align="center">75 (69.4%)</td><td rowspan="1" colspan="1" valign="top" align="center">427 (63.6%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Treatment, N(%)</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> Implant Only</td><td rowspan="1" colspan="1" valign="top" align="center">39 (49.4%)</td><td rowspan="1" colspan="1" valign="top" align="center">167 (57.8%)</td><td rowspan="1" colspan="1" valign="top" align="center">221 (55.9%)</td><td rowspan="1" colspan="1" valign="top" align="center">4 (3.7%)</td><td rowspan="1" colspan="1" valign="top" align="center">59 (8.9%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> Implant + EBRT</td><td rowspan="1" colspan="1" valign="top" align="center">38 (48.1%)</td><td rowspan="1" colspan="1" valign="top" align="center">122 (42.2%)</td><td rowspan="1" colspan="1" valign="top" align="center">164 (41.5%)</td><td rowspan="1" colspan="1" valign="top" align="center">5 (4.6%)</td><td rowspan="1" colspan="1" valign="top" align="center">33 (5.0%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> EBRT Only</td><td rowspan="1" colspan="1" valign="top" align="center">2 (2.5%)</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="1" colspan="1" valign="top" align="center">10 (2.5%)</td><td rowspan="1" colspan="1" valign="top" align="center">99 (91.7%)</td><td rowspan="1" colspan="1" valign="top" align="center">573 (86.2%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Total BED (Gy2), mean(sd)</td><td rowspan="1" colspan="1" valign="top" align="center">201.3 (23.6)</td><td rowspan="1" colspan="1" valign="top" align="center">203.9 (22.1)</td><td rowspan="1" colspan="1" valign="top" align="center">200.5 (28.0)</td><td rowspan="1" colspan="1" valign="top" align="center">148.2 (36.2)</td><td rowspan="1" colspan="1" valign="top" align="center">148.7 (30.8)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Rectum V100, mean(sd)</td><td rowspan="1" colspan="1" valign="top" align="center">1.00 (0.76)</td><td rowspan="1" colspan="1" valign="top" align="center">0.91 (0.71)</td><td rowspan="1" colspan="1" valign="top" align="center">0.89 (0.87)</td><td rowspan="1" colspan="1" valign="top" align="center">NA</td><td rowspan="1" colspan="1" valign="top" align="center">NA</td></tr></tbody></table></div><div id="largeobj_idm139767453473008" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3787843/table/T1/?report=objectonly">Open in a separate window</a></div></div><p id="P11">In the pooled replication set, the CHUS cohort consisted of 403 patients from the RADIOGEN trial treated with EBRT [<a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_336455995">10</a>]. Total delivered dose ranged from 50 to 76 (median 74) Gy with 1.8 to 2.0 Gy per fraction. 311 (77.2%) patients also received hormonal therapy. The MAASTRO cohort consisted of 203 patients treated with EBRT alone (144 patients; 70.9%) prescribed to 68–72Gy in 2.0 Gy fractions or with brachytherapy alone (59 patients; 29.1%) prescribed to 145Gy. 111 patients (54.7%) also received hormonal therapy. The CCI cohort consisted of 153 patients treated with EBRT. Hypo-fraction regimens were given to 33 (21.6%) patients and consisted of 68Gy in 25 fractions or 55Gy in 16 fractions. Standard fraction was delivered to 120 (78.4%) patients with 72 to 82Gy delivered in 1.8 to 2Gy per fraction. Hormonal therapy was given to 77 (50.3%) patients. The FROG cohort consisted of 52 patients. The treatment regimen and technique were similar to the MSMC group. Treatment included <sup>125</sup>I brachytherapy (5 patients; 9.6%), <sup>103</sup>Pd brachytherapy with EBRT (38 patients; 73.1%), or EBRT alone (9 patients; 17.2%). 28 patients (53.8%) received hormonal therapy as part of their treatment. EBRT patients were all treated with IMRT technique. Total doses ranged from 64.8 to 81 Gy using 1.8Gy fractions. Total biologically effective dose was calculated among all cohorts using previously published methods with an α/β of 2 [<a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_336455983">11</a>].</p><p id="P12" class="p p-last">All men were followed prospectively for development of rectal bleeding. Included patients had at least one year of follow-up, and late (&gt;90 days post-RT) rectal bleeding was considered. Rectal bleeding was assessed as follows: in the MSMC and FROG patients using the Radiation Therapy Oncology Group (RTOG) late radiation morbidity scoring schema; in the CHUS and CCI patients using National Cancer Institute Common Toxicity Criteria for Adverse Events (CTCAE) version 3; and in the MAASTRO patients using a patient self-report questionnaire, which was harmonized to the RTOG grading scheme (see <a href="#SD4" rid="SD4" class=" supplementary-material">Appendix</a> for detailed descriptions). For all cohorts, rectal bleeding grade was assigned by a physician based on patient-reported description of symptoms. Care was taken to ensure comparability in case/control definitions across cohorts. Patients with grade 2 or higher rectal bleeding were considered cases and patients with grade 0 or 1 were considered controls.</p></div><div id="S8" class="sec"><h3 id="S8title">Genotyping and Quality Control</h3><p id="P13" class="p p-first">Genomic DNA was isolated from lymphocytes. DNA from men in the discovery cohort was genotyped for ~900,000 SNPs using Affymetrix v6.0 genome-wide arrays, and genotypes were called using Genotyping Console (Affymetrix, Santa Clara, CA). DNA from men in the CHUS, MAASTRO and FROG replication cohorts was genotyped using Illumina iSelect custom SNP arrays, and genotypes were called by GenomeStudio (Illumina, San Diego, CA). DNA from men in the CCI cohort was genotyped using Affymetrix v6.0 genome-wide arrays, but these samples were only analyzed for SNPs included in the replication study and present on the Illumina array. SNPs were excluded from analysis if missing in &gt;5% of samples (137,589 SNPs in the discovery dataset; 14 SNPs in the replication dataset), if they had minor allele frequency (MAF) &lt;5% (157,580 SNPs in the discovery dataset), or if they showed deviation from Hardy-Weinberg equilibrium (p-value &lt; 1×10<sup>−5</sup>; 5,433 SNPs in the discovery dataset). Individuals were excluded if they showed cryptic relatedness (8 pairs) or if they had call rate &lt;90% (24 individuals). Duplicate samples and a trio of HapMap samples were included in both rounds of genotyping and showed &gt;98% concordance. PLINKv1.07 was used for quality control and SNP association tests [<a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_336455992">12</a>].</p><p id="P14" class="p p-last">Principal components analysis (PCA) was performed to assess and control for individual genetic ethnicity using 11 reference populations from the International HapMap Project [<a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_336455981">13</a>]. PCA was performed using 860 ancestry-informative markers. SNP data processing and PCA was carried out using R [<a href="#R14" rid="R14" class=" bibr popnode">14</a>].</p></div><div id="S9" class="sec sec-last"><h3 id="S9title">Statistical Analysis</h3><p id="P15" class="p p-first">Association between clinical and demographic variables and rectal bleeding was assessed using chi-square test and one-way analysis of variance. IBM SPSS Statistics 19 was used for statistical tests.</p><p id="P16">Tests for association between each SNP and rectal bleeding were carried out using multivariable logistic regression including the first five principle components (to control for ethnicity) as well as study site in the replication stage (to control for differences in treatment across the four sites). Fisher’s trend method was used to combine p-values from the discovery and replication studies [<a href="#R15" rid="R15" class=" bibr popnode">15</a>].</p><p id="P17" class="p p-last">A polygenic risk score was computed by assigning a numeric count of risk alleles for each SNP and then adding together the number of risk alleles for the replicated SNPs. For SNPs showing an additive inheritance mode, homozygotes for the risk allele were assigned 1 point, heterozygotes were assigned 0.5 points, and homozygotes for the non-risk allele were assigned 0 points. For SNPs with either dominant or recessive inheritance mode, the appropriate genotype categories were collapsed so that those with the risk genotype(s) were assigned 1 point and those without the risk genotype(s) were assigned 0 points. Rank-correlation between the polygenic risk score and rectal bleeding was assessed using Somers’ d.</p></div></div><div id="S10" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S10title">Results</h2><p id="P18" class="p p-first">Among 1,572 men with prostate adenocarcinoma who met the inclusion criteria for the study, 188 (12.0%) developed significant (≥ grade 2 or equivalent severity; <a href="#SD4" rid="SD4" class=" supplementary-material">Appendix 1</a>) late rectal bleeding. The incidence of rectal bleeding was similar across study sites: 80 out of 764 (10.5%) at MSMC; 41 out of 403 (10.2%) at CHUS; 36 out of 203 (17.7%) at MAASTRO; 26 out of 153 (17.0%) at CCI; and 6 out of 52 (11.5%) at FROG. The mean length of follow-up for assessing rectal bleeding was similar between cases and controls in both the discovery and replication cohorts (50 months for cases vs. 48 months for controls in the MSMC cohort and 40 months for cases vs. 41 months for controls in the replication).</p><p id="P19">A genome-wide association study (GWAS) was performed to identify SNPs associated with development of rectal bleeding in the MSMC discovery cohort (79 cases and 289 controls), and top SNPs were investigated in the pooled replication cohort (108 cases and 673 controls). <a href="/pmc/articles/PMC3787843/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a> shows the characteristics of the patients included in the GWAS. On univariate analysis, there were no statistically significant differences (p&lt;0.05) in age, Gleason score, treatment modality, or use of hormonal therapy between cases and controls in either the MSMC cohort or the pooled replication cohort. Total biologically effective dose (BED) was similar between cases and controls in the MSMC cohort and the pooled replication cohort, though the majority of the MSMC patients were treated with brachytherapy whereas the replication cohort patients were largely treated with external beam RT and received, on average, lower doses (<a href="/pmc/articles/PMC3787843/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>).</p><p id="P20">After quality control, 614,453 SNPs were investigated for association with rectal bleeding in the MSMC discovery cohort. Consistent with self-reported race/ethnicity, PCA confirmed that the majority of the patients were of European ancestry, with approximately 25% showing African, Hispanic, and/or Asian ancestry (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure 1</a>). Inclusion of the first five principle components in association tests adequately controlled for ethnicity as evidenced by a low genomic inflation factor (1.02) after correction (<a href="#SD2" rid="SD2" class=" supplementary-material">Supplementary Figure 2</a>). A total of 491 SNPs were identified with p-values between 3.1×10<sup>−10</sup> and 9.9×10<sup>−4</sup> in the discovery cohort, and these SNPs were tested in the pooled replication cohort. A region on chromosome 11q14.3 contained two SNPs, rs7120482 and rs17630638, which have Fisher combined p-values reaching or near genome-wide significance (5.4×10<sup>−8</sup> and 6.9×10<sup>−7</sup> respectively) and show the same odds ratio directionality and inheritance model in the discovery and replication cohorts (<a href="#SD3" rid="SD3" class=" supplementary-material">Supplementary Table 1</a>). These two SNPs are in strong linkage disequilibrium (r<sup>2</sup>=1.0 in the HapMap CEU population) and likely tag a single risk locus. Two other SNPs were identified that have Fisher combined p-values near genome-wide significance: rs10519410 on 4q28.3 nearest the <em>PCDH18</em> gene (combined p-value = 1.3×10<sup>−6</sup>) and rs10255878 on 7q21.3 nearest the <em>ACN9</em> gene (combined p-value = 3.6×10<sup>−6</sup>). Several other SNPs showed a trend towards significance, with combined p-values &lt; 5.0×10<sup>−4</sup> (<a href="#SD3" rid="SD3" class=" supplementary-material">Supplementary Table 1</a>). Though each individual study site in the replication cohort is underpowered to detect statistically significant associations, we confirmed agreement in odds ratio directionality in each study site for all SNPs listed in <a href="#SD3" rid="SD3" class=" supplementary-material">Supplementary Table 1</a>.</p><p id="P21">In a related GWAS of erectile dysfunction following radiotherapy, a polygenic risk score representing the sum total number of risk alleles an individual possessed, as a quantitative measure of genetic risk, showed a stronger association signal than any single SNP alone [<a href="#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_336455986">16</a>]. Here, we see a similar effect using the top 17 SNPs associated with rectal bleeding (excluding rs17630638 and rs7111590, which are in linkage disequilibrium with a SNP already included). After controlling for ethnicity and study site, the polygenic risk score had an odds ratio of 3.0 (95% CI 2.4–3.9; p-value 5.4×10<sup>−18</sup>) in the discovery cohort and an odds ratio of 1.7 (95% CI 1.5–1.9; p-value 6.4×10<sup>−13</sup>) in the replication cohort. Similarly, there was a strong rank-correlation between number of total risk alleles out of these 17 SNPs and rectal bleeding (Sommers’ d p-value = 1.6×10<sup>−28</sup> in the discovery cohort; 5.0×10<sup>−12</sup> in the replication cohort; <a href="/pmc/articles/PMC3787843/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>). When used to predict the probability of developing rectal bleeding, the polygenic risk score produces an area under the receiver operating characteristic curve (AUC) of 0.892 in the discovery cohort and 0.737 in the replication cohort. It should be noted, the odds ratio and AUC for the discovery cohort is an overly optimistic estimate precisely because this cohort was used for discovery. Furthermore, the per-allele increase in odds of developing rectal bleeding may be non-linear over the set of predictive SNPs, and it will be important to refine this model following validation studies.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T2"><h3>Table 2</h3><!--caption a7--><div class="caption"><p id="__p8">Rank-correlation between cumulative number of risk alleles summed for the top 17 SNPs and rectal bleeding case/control status in the discovery and replication cohorts.</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139767455976320" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="2" colspan="1" valign="bottom" align="center">Number of risk alleles</th><th colspan="2" rowspan="1" valign="bottom" align="center">Discovery Cohort</th><th colspan="2" rowspan="1" valign="bottom" align="center">Replication Cohort</th></tr><tr><th rowspan="1" colspan="1" valign="bottom" align="center">Cases<br>N = 79</th><th rowspan="1" colspan="1" valign="bottom" align="center">Controls<br>N = 241</th><th rowspan="1" colspan="1" valign="bottom" align="center">Cases<br>N = 107</th><th rowspan="1" colspan="1" valign="bottom" align="center">Controls<br>N = 671</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="1" colspan="1" valign="top" align="center">1 (0.1%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">0.5</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="1" colspan="1" valign="top" align="center">0</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">1</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="1" colspan="1" valign="top" align="center">2 (0.7%)</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="1" colspan="1" valign="top" align="center">4 (0.6%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">1.5</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="1" colspan="1" valign="top" align="center">2 (0.7%)</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="1" colspan="1" valign="top" align="center">11 (1.6%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">2</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="1" colspan="1" valign="top" align="center">12 (4.2%)</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="1" colspan="1" valign="top" align="center">13 (1.9%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">2.5</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="1" colspan="1" valign="top" align="center">25 (8.7%)</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="1" colspan="1" valign="top" align="center">33 (4.9%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">3</td><td rowspan="1" colspan="1" valign="top" align="center">1 (1.3%)</td><td rowspan="1" colspan="1" valign="top" align="center">25 (8.7%)</td><td rowspan="1" colspan="1" valign="top" align="center">6 (5.6%)</td><td rowspan="1" colspan="1" valign="top" align="center">48 (7.1%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">3.5</td><td rowspan="1" colspan="1" valign="top" align="center">1 (1.3%)</td><td rowspan="1" colspan="1" valign="top" align="center">44 (15.2%)</td><td rowspan="1" colspan="1" valign="top" align="center">3 (2.8%)</td><td rowspan="1" colspan="1" valign="top" align="center">48 (7.1%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">4</td><td rowspan="1" colspan="1" valign="top" align="center">2 (2.5%)</td><td rowspan="1" colspan="1" valign="top" align="center">42 (14.5%)</td><td rowspan="1" colspan="1" valign="top" align="center">9 (8.4%)</td><td rowspan="1" colspan="1" valign="top" align="center">95 (14.1%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">4.5</td><td rowspan="1" colspan="1" valign="top" align="center">2 (2.5%)</td><td rowspan="1" colspan="1" valign="top" align="center">28 (9.7%)</td><td rowspan="1" colspan="1" valign="top" align="center">9 (8.4%)</td><td rowspan="1" colspan="1" valign="top" align="center">86 (12.8%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">5</td><td rowspan="1" colspan="1" valign="top" align="center">7 (8.9%)</td><td rowspan="1" colspan="1" valign="top" align="center">33 (11.4%)</td><td rowspan="1" colspan="1" valign="top" align="center">10 (9.3%)</td><td rowspan="1" colspan="1" valign="top" align="center">97 (14.4%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">5.5</td><td rowspan="1" colspan="1" valign="top" align="center">4 (5.1%)</td><td rowspan="1" colspan="1" valign="top" align="center">32 (11.1%)</td><td rowspan="1" colspan="1" valign="top" align="center">9 (8.4%)</td><td rowspan="1" colspan="1" valign="top" align="center">66 (9.8%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">6</td><td rowspan="1" colspan="1" valign="top" align="center">12 (15.2%)</td><td rowspan="1" colspan="1" valign="top" align="center">20 (6.9%)</td><td rowspan="1" colspan="1" valign="top" align="center">15 (14.0%)</td><td rowspan="1" colspan="1" valign="top" align="center">49 (7.3%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">6.5</td><td rowspan="1" colspan="1" valign="top" align="center">5 (6.3%)</td><td rowspan="1" colspan="1" valign="top" align="center">10 (3.5%)</td><td rowspan="1" colspan="1" valign="top" align="center">13 (12.1%)</td><td rowspan="1" colspan="1" valign="top" align="center">40 (5.9%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">7</td><td rowspan="1" colspan="1" valign="top" align="center">9 (11.4%)</td><td rowspan="1" colspan="1" valign="top" align="center">3 (1.0%)</td><td rowspan="1" colspan="1" valign="top" align="center">13 (12.1%)</td><td rowspan="1" colspan="1" valign="top" align="center">23 (3.4%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">7.5</td><td rowspan="1" colspan="1" valign="top" align="center">11 (13.9%)</td><td rowspan="1" colspan="1" valign="top" align="center">7 (2.4%)</td><td rowspan="1" colspan="1" valign="top" align="center">10 (9.3%)</td><td rowspan="1" colspan="1" valign="top" align="center">16 (2.4%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">8</td><td rowspan="1" colspan="1" valign="top" align="center">6 (7.6%)</td><td rowspan="1" colspan="1" valign="top" align="center">3 (1.0%)</td><td rowspan="1" colspan="1" valign="top" align="center">6 (5.6%)</td><td rowspan="1" colspan="1" valign="top" align="center">7 (1.0%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">8.5</td><td rowspan="1" colspan="1" valign="top" align="center">4 (5.1%)</td><td rowspan="1" colspan="1" valign="top" align="center">1 (0.3%)</td><td rowspan="1" colspan="1" valign="top" align="center">1 (0.9%)</td><td rowspan="1" colspan="1" valign="top" align="center">6 (0.9%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">9</td><td rowspan="1" colspan="1" valign="top" align="center">5 (6.3%)</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="1" colspan="1" valign="top" align="center">3 (2.8%)</td><td rowspan="1" colspan="1" valign="top" align="center">3 (0.4%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">9.5</td><td rowspan="1" colspan="1" valign="top" align="center">5 (6.3%)</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="1" colspan="1" valign="top" align="center">3 (0.4%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">10</td><td rowspan="1" colspan="1" valign="top" align="center">2 (2.5%)</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="1" colspan="1" valign="top" align="center">1 (0.1%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">10.5</td><td rowspan="1" colspan="1" valign="top" align="center">2 (2.5%)</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="1" colspan="1" valign="top" align="center">0</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">11</td><td rowspan="1" colspan="1" valign="top" align="center">1 (1.3%)</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="1" colspan="1" valign="top" align="center">0</td></tr></tbody></table></div><div id="largeobj_idm139767455976320" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3787843/table/T2/?report=objectonly">Open in a separate window</a></div></div><p id="P22" class="p p-last">Previous studies found SNPs in DNA damage and inflammatory response genes (<em>ATM</em>, <em>LIG4</em>, <em>ERCC2CP2D6*4</em>, <em>MDC1</em>, <em>SOD2</em>, <em>XRCC3</em> and <em>TGFB1</em>) to be associated with rectal toxicity. Data was available for 18 of these published SNPs in either some or all of the patients in the current study. Two of the SNPs, rs1800935 in <em>MSH6</em> and rs4803455 in <em>TGFB1</em>, have dominant-model p-values &lt;0.05, but these are not significant after correction for multiple comparisons (<a href="/pmc/articles/PMC3787843/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>). All other SNPs available for testing had non-significant p-values.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T3"><h3>Table 3</h3><!--caption a7--><div class="caption"><p id="__p9">Association between previously published candidate SNPs and rectal bleeding. OR is risk for grade 2 or higher proctitis compared to grade 0 or 1 proctitis.</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139767493181328" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="2" colspan="1" valign="bottom" align="center">dbSNPrsID</th><th rowspan="2" colspan="1" valign="bottom" align="center">Gene</th><th rowspan="2" colspan="1" valign="bottom" align="center">Chr</th><th rowspan="2" colspan="1" valign="bottom" align="center">NCBI36/hg18bp</th><th rowspan="2" colspan="1" valign="bottom" align="center">Minor Allele</th><th rowspan="2" colspan="1" valign="bottom" align="center">MAF Cases</th><th rowspan="2" colspan="1" valign="bottom" align="center">MAF Controls</th><th colspan="2" rowspan="1" valign="bottom" align="center">Allelic</th><th colspan="2" rowspan="1" valign="bottom" align="center">Dominant</th><th colspan="2" rowspan="1" valign="bottom" align="center">Recessive</th></tr><tr><th rowspan="1" colspan="1" valign="bottom" align="center">OR</th><th rowspan="1" colspan="1" valign="bottom" align="center">p-value</th><th rowspan="1" colspan="1" valign="bottom" align="center">OR</th><th rowspan="1" colspan="1" valign="bottom" align="center">p-value</th><th rowspan="1" colspan="1" valign="bottom" align="center">OR</th><th rowspan="1" colspan="1" valign="bottom" align="center">p-value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="center">rs1800935<sup>*</sup></td><td rowspan="1" colspan="1" valign="top" align="center"><em>MSH6</em></td><td rowspan="1" colspan="1" valign="top" align="center">2</td><td rowspan="1" colspan="1" valign="top" align="center">47876619</td><td rowspan="1" colspan="1" valign="top" align="center">C</td><td rowspan="1" colspan="1" valign="top" align="center">0.17</td><td rowspan="1" colspan="1" valign="top" align="center">0.25</td><td rowspan="1" colspan="1" valign="top" align="center">0.6</td><td rowspan="1" colspan="1" valign="top" align="center">0.06</td><td rowspan="1" colspan="1" valign="top" align="center">0.5</td><td rowspan="1" colspan="1" valign="top" align="center">0.03</td><td rowspan="1" colspan="1" valign="top" align="center">0.8</td><td rowspan="1" colspan="1" valign="top" align="center">0.63</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs9262152<sup>*</sup></td><td rowspan="1" colspan="1" valign="top" align="center"><em>MDC1</em></td><td rowspan="1" colspan="1" valign="top" align="center">6</td><td rowspan="1" colspan="1" valign="top" align="center">30788895</td><td rowspan="1" colspan="1" valign="top" align="center">T</td><td rowspan="1" colspan="1" valign="top" align="center">0.12</td><td rowspan="1" colspan="1" valign="top" align="center">0.14</td><td rowspan="1" colspan="1" valign="top" align="center">0.9</td><td rowspan="1" colspan="1" valign="top" align="center">0.69</td><td rowspan="1" colspan="1" valign="top" align="center">0.9</td><td rowspan="1" colspan="1" valign="top" align="center">0.21</td><td rowspan="1" colspan="1" valign="top" align="center">0.5</td><td rowspan="1" colspan="1" valign="top" align="center">0.15</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs1801132<sup>*</sup></td><td rowspan="1" colspan="1" valign="top" align="center"><em>ESR1</em></td><td rowspan="1" colspan="1" valign="top" align="center">6</td><td rowspan="1" colspan="1" valign="top" align="center">152307215</td><td rowspan="1" colspan="1" valign="top" align="center">G</td><td rowspan="1" colspan="1" valign="top" align="center">0.16</td><td rowspan="1" colspan="1" valign="top" align="center">0.18</td><td rowspan="1" colspan="1" valign="top" align="center">0.9</td><td rowspan="1" colspan="1" valign="top" align="center">0.62</td><td rowspan="1" colspan="1" valign="top" align="center">0.9</td><td rowspan="1" colspan="1" valign="top" align="center">0.69</td><td rowspan="1" colspan="1" valign="top" align="center">0.8</td><td rowspan="1" colspan="1" valign="top" align="center">0.50</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs776746<sup>*</sup></td><td rowspan="1" colspan="1" valign="top" align="center"><em>CY3A5</em><sup>*</sup><em>3</em></td><td rowspan="1" colspan="1" valign="top" align="center">7</td><td rowspan="1" colspan="1" valign="top" align="center">99108475</td><td rowspan="1" colspan="1" valign="top" align="center">T</td><td rowspan="1" colspan="1" valign="top" align="center">0.22</td><td rowspan="1" colspan="1" valign="top" align="center">0.18</td><td rowspan="1" colspan="1" valign="top" align="center">1.2</td><td rowspan="1" colspan="1" valign="top" align="center">0.55</td><td rowspan="1" colspan="1" valign="top" align="center">1.3</td><td rowspan="1" colspan="1" valign="top" align="center">0.34</td><td rowspan="1" colspan="1" valign="top" align="center">1.5</td><td rowspan="1" colspan="1" valign="top" align="center">0.38</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs1805794<sup>*</sup></td><td rowspan="1" colspan="1" valign="top" align="center"><em>NBN</em></td><td rowspan="1" colspan="1" valign="top" align="center">8</td><td rowspan="1" colspan="1" valign="top" align="center">91059655</td><td rowspan="1" colspan="1" valign="top" align="center">G</td><td rowspan="1" colspan="1" valign="top" align="center">0.28</td><td rowspan="1" colspan="1" valign="top" align="center">0.30</td><td rowspan="1" colspan="1" valign="top" align="center">0.9</td><td rowspan="1" colspan="1" valign="top" align="center">0.68</td><td rowspan="1" colspan="1" valign="top" align="center">0.7</td><td rowspan="1" colspan="1" valign="top" align="center">0.62</td><td rowspan="1" colspan="1" valign="top" align="center">1.8</td><td rowspan="1" colspan="1" valign="top" align="center">0.75</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs1800054</td><td rowspan="1" colspan="1" valign="top" align="center"><em>ATM</em></td><td rowspan="1" colspan="1" valign="top" align="center">11</td><td rowspan="1" colspan="1" valign="top" align="center">108098576</td><td rowspan="1" colspan="1" valign="top" align="center">G</td><td rowspan="1" colspan="1" valign="top" align="center">0.01</td><td rowspan="1" colspan="1" valign="top" align="center">0.01</td><td rowspan="1" colspan="1" valign="top" align="center">0.7</td><td rowspan="1" colspan="1" valign="top" align="center">0.69</td><td rowspan="1" colspan="1" valign="top" align="center">NA</td><td rowspan="1" colspan="1" valign="top" align="center">NA</td><td rowspan="1" colspan="1" valign="top" align="center">NA</td><td rowspan="1" colspan="1" valign="top" align="center">NA</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs4986761</td><td rowspan="1" colspan="1" valign="top" align="center"><em>ATM</em></td><td rowspan="1" colspan="1" valign="top" align="center">11</td><td rowspan="1" colspan="1" valign="top" align="center">108124761</td><td rowspan="1" colspan="1" valign="top" align="center">G</td><td rowspan="1" colspan="1" valign="top" align="center">0.01</td><td rowspan="1" colspan="1" valign="top" align="center">0.01</td><td rowspan="1" colspan="1" valign="top" align="center">1.1</td><td rowspan="1" colspan="1" valign="top" align="center">0.88</td><td rowspan="1" colspan="1" valign="top" align="center">NA</td><td rowspan="1" colspan="1" valign="top" align="center">NA</td><td rowspan="1" colspan="1" valign="top" align="center">NA</td><td rowspan="1" colspan="1" valign="top" align="center">NA</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs1800057</td><td rowspan="1" colspan="1" valign="top" align="center"><em>ATM</em></td><td rowspan="1" colspan="1" valign="top" align="center">11</td><td rowspan="1" colspan="1" valign="top" align="center">108143456</td><td rowspan="1" colspan="1" valign="top" align="center">C</td><td rowspan="1" colspan="1" valign="top" align="center">0.04</td><td rowspan="1" colspan="1" valign="top" align="center">0.02</td><td rowspan="1" colspan="1" valign="top" align="center">1.5</td><td rowspan="1" colspan="1" valign="top" align="center">0.22</td><td rowspan="1" colspan="1" valign="top" align="center">NA</td><td rowspan="1" colspan="1" valign="top" align="center">NA</td><td rowspan="1" colspan="1" valign="top" align="center">NA</td><td rowspan="1" colspan="1" valign="top" align="center">NA</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs1805386</td><td rowspan="1" colspan="1" valign="top" align="center"><em>LIG4</em></td><td rowspan="1" colspan="1" valign="top" align="center">13</td><td rowspan="1" colspan="1" valign="top" align="center">108861913</td><td rowspan="1" colspan="1" valign="top" align="center">C</td><td rowspan="1" colspan="1" valign="top" align="center">0.20</td><td rowspan="1" colspan="1" valign="top" align="center">0.17</td><td rowspan="1" colspan="1" valign="top" align="center">1.2</td><td rowspan="1" colspan="1" valign="top" align="center">0.22</td><td rowspan="1" colspan="1" valign="top" align="center">1.2</td><td rowspan="1" colspan="1" valign="top" align="center">0.41</td><td rowspan="1" colspan="1" valign="top" align="center">2.1</td><td rowspan="1" colspan="1" valign="top" align="center">0.08</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs1799794</td><td rowspan="1" colspan="1" valign="top" align="center"><em>XRCC3</em></td><td rowspan="1" colspan="1" valign="top" align="center">14</td><td rowspan="1" colspan="1" valign="top" align="center">104179267</td><td rowspan="1" colspan="1" valign="top" align="center">C</td><td rowspan="1" colspan="1" valign="top" align="center">0.26</td><td rowspan="1" colspan="1" valign="top" align="center">0.26</td><td rowspan="1" colspan="1" valign="top" align="center">1.0</td><td rowspan="1" colspan="1" valign="top" align="center">0.93</td><td rowspan="1" colspan="1" valign="top" align="center">1.0</td><td rowspan="1" colspan="1" valign="top" align="center">0.96</td><td rowspan="1" colspan="1" valign="top" align="center">1.1</td><td rowspan="1" colspan="1" valign="top" align="center">0.81</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs8110090</td><td rowspan="1" colspan="1" valign="top" align="center"><em>TGFB1</em></td><td rowspan="1" colspan="1" valign="top" align="center">19</td><td rowspan="1" colspan="1" valign="top" align="center">41845872</td><td rowspan="1" colspan="1" valign="top" align="center">G</td><td rowspan="1" colspan="1" valign="top" align="center">0.07</td><td rowspan="1" colspan="1" valign="top" align="center">0.07</td><td rowspan="1" colspan="1" valign="top" align="center">1.0</td><td rowspan="1" colspan="1" valign="top" align="center">0.84</td><td rowspan="1" colspan="1" valign="top" align="center">NA</td><td rowspan="1" colspan="1" valign="top" align="center">NA</td><td rowspan="1" colspan="1" valign="top" align="center">NA</td><td rowspan="1" colspan="1" valign="top" align="center">NA</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs4803455</td><td rowspan="1" colspan="1" valign="top" align="center"><em>TGFB1</em></td><td rowspan="1" colspan="1" valign="top" align="center">19</td><td rowspan="1" colspan="1" valign="top" align="center">41851509</td><td rowspan="1" colspan="1" valign="top" align="center">A</td><td rowspan="1" colspan="1" valign="top" align="center">0.44</td><td rowspan="1" colspan="1" valign="top" align="center">0.49</td><td rowspan="1" colspan="1" valign="top" align="center">0.8</td><td rowspan="1" colspan="1" valign="top" align="center">0.07</td><td rowspan="1" colspan="1" valign="top" align="center">0.7</td><td rowspan="1" colspan="1" valign="top" align="center">0.04</td><td rowspan="1" colspan="1" valign="top" align="center">0.8</td><td rowspan="1" colspan="1" valign="top" align="center">0.41</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs1800470</td><td rowspan="1" colspan="1" valign="top" align="center"><em>TGFB1</em></td><td rowspan="1" colspan="1" valign="top" align="center">19</td><td rowspan="1" colspan="1" valign="top" align="center">41858921</td><td rowspan="1" colspan="1" valign="top" align="center">G</td><td rowspan="1" colspan="1" valign="top" align="center">0.45</td><td rowspan="1" colspan="1" valign="top" align="center">0.41</td><td rowspan="1" colspan="1" valign="top" align="center">1.2</td><td rowspan="1" colspan="1" valign="top" align="center">0.29</td><td rowspan="1" colspan="1" valign="top" align="center">1.2</td><td rowspan="1" colspan="1" valign="top" align="center">0.40</td><td rowspan="1" colspan="1" valign="top" align="center">1.3</td><td rowspan="1" colspan="1" valign="top" align="center">0.38</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs1800469</td><td rowspan="1" colspan="1" valign="top" align="center"><em>TGFB1</em></td><td rowspan="1" colspan="1" valign="top" align="center">19</td><td rowspan="1" colspan="1" valign="top" align="center">41860296</td><td rowspan="1" colspan="1" valign="top" align="center">A</td><td rowspan="1" colspan="1" valign="top" align="center">0.38</td><td rowspan="1" colspan="1" valign="top" align="center">0.34</td><td rowspan="1" colspan="1" valign="top" align="center">1.2</td><td rowspan="1" colspan="1" valign="top" align="center">0.17</td><td rowspan="1" colspan="1" valign="top" align="center">1.2</td><td rowspan="1" colspan="1" valign="top" align="center">0.24</td><td rowspan="1" colspan="1" valign="top" align="center">1.3</td><td rowspan="1" colspan="1" valign="top" align="center">0.32</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs25487</td><td rowspan="1" colspan="1" valign="top" align="center"><em>XRCC1</em></td><td rowspan="1" colspan="1" valign="top" align="center">19</td><td rowspan="1" colspan="1" valign="top" align="center">44055726</td><td rowspan="1" colspan="1" valign="top" align="center">A</td><td rowspan="1" colspan="1" valign="top" align="center">0.28</td><td rowspan="1" colspan="1" valign="top" align="center">0.31</td><td rowspan="1" colspan="1" valign="top" align="center">0.9</td><td rowspan="1" colspan="1" valign="top" align="center">0.54</td><td rowspan="1" colspan="1" valign="top" align="center">1.0</td><td rowspan="1" colspan="1" valign="top" align="center">0.93</td><td rowspan="1" colspan="1" valign="top" align="center">0.5</td><td rowspan="1" colspan="1" valign="top" align="center">0.21</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs25489</td><td rowspan="1" colspan="1" valign="top" align="center"><em>XRCC1</em></td><td rowspan="1" colspan="1" valign="top" align="center">19</td><td rowspan="1" colspan="1" valign="top" align="center">44056412</td><td rowspan="1" colspan="1" valign="top" align="center">T</td><td rowspan="1" colspan="1" valign="top" align="center">0.04</td><td rowspan="1" colspan="1" valign="top" align="center">0.05</td><td rowspan="1" colspan="1" valign="top" align="center">0.8</td><td rowspan="1" colspan="1" valign="top" align="center">0.59</td><td rowspan="1" colspan="1" valign="top" align="center">0.9</td><td rowspan="1" colspan="1" valign="top" align="center">NA</td><td rowspan="1" colspan="1" valign="top" align="center">0.00</td><td rowspan="1" colspan="1" valign="top" align="center">NA</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs1799782</td><td rowspan="1" colspan="1" valign="top" align="center"><em>XRCC1</em></td><td rowspan="1" colspan="1" valign="top" align="center">19</td><td rowspan="1" colspan="1" valign="top" align="center">44057574</td><td rowspan="1" colspan="1" valign="top" align="center">T</td><td rowspan="1" colspan="1" valign="top" align="center">0.06</td><td rowspan="1" colspan="1" valign="top" align="center">0.07</td><td rowspan="1" colspan="1" valign="top" align="center">0.8</td><td rowspan="1" colspan="1" valign="top" align="center">0.51</td><td rowspan="1" colspan="1" valign="top" align="center">0.7</td><td rowspan="1" colspan="1" valign="top" align="center">0.36</td><td rowspan="1" colspan="1" valign="top" align="center">3.6</td><td rowspan="1" colspan="1" valign="top" align="center">0.24</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs1052555</td><td rowspan="1" colspan="1" valign="top" align="center"><em>ERCC2</em></td><td rowspan="1" colspan="1" valign="top" align="center">19</td><td rowspan="1" colspan="1" valign="top" align="center">45855524</td><td rowspan="1" colspan="1" valign="top" align="center">T</td><td rowspan="1" colspan="1" valign="top" align="center">0.34</td><td rowspan="1" colspan="1" valign="top" align="center">0.32</td><td rowspan="1" colspan="1" valign="top" align="center">1.1</td><td rowspan="1" colspan="1" valign="top" align="center">0.54</td><td rowspan="1" colspan="1" valign="top" align="center">1.3</td><td rowspan="1" colspan="1" valign="top" align="center">0.16</td><td rowspan="1" colspan="1" valign="top" align="center">0.7</td><td rowspan="1" colspan="1" valign="top" align="center">0.34</td></tr></tbody></table></div><div id="largeobj_idm139767493181328" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3787843/table/T3/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN1"><sup>*</sup>Genotyped in only the Discovery cohort samples; all others were genotyped in both the Discovery and Replication cohorts.</div></div></div></div><div id="S11" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S11title">Discussion</h2><p id="P23" class="p p-first">The rationale for embarking upon the current study is that previous research has been narrowly focused upon specific genes involved in radiation response and DNA repair pathways. We sought to genotype broadly on a genome-wide level and to use the results of the discovery GWAS to focus on a subset of SNPs for validation in replication cohorts. To our knowledge, this is the first genome-wide approach to identify SNPs associated with late rectal toxicity after radiotherapy. Using this approach, we identified a set of candidate SNPs that may be useful in predicting which patients are at risk for development of rectal bleeding following treatment.</p><p id="P24">Rectal bleeding following radiation is a microangiopathic condition with increased vascular proliferation. The candidate genes located in proximity to some of the significant SNPs in this study may encode products that serve roles in restraining vascular proliferation. The <em>SLC36A4</em> gene that is downstream of the two significant SNPs, rs7120482 and rs17630638, encodes a non-proton coupled amino acid transporter that is required for normal cellular proliferation [<a href="#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_336455991">17</a>]. Specifically, it modulates the activity of the mammalian target of rapamycin complex 1 (mTORC1) signaling cascade which affects angiogenesis, proliferation and cell survival, among other functions [<a href="#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_336455990">17</a>]. Interestingly, mTOR signaling has been shown to play a role in radiosensitization in a number of studies across various tumor types, including prostate [<a href="#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_336455996">18</a>–<a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_336455982">19</a>]. SNP rs4904509 lies just upstream of <em>FOXN3</em>, which was identified as a novel DNA-damage checkpoint suppressor protein in a yeast genetic screen [<a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_336455985">20</a>]. This SNP did not show as strong an association signal in the replication cohort, but may warrant further investigation due to its relevant biological mechanism. Fine-mapping studies will be needed to confirm which genes are affected by the tag SNPs identified here before functional studies can be undertaken.</p><p id="P25">Our study provides an important replication cohort for the SNPs previously studied in the context of rectal toxicity. None showed significant association after correction for multiple comparisons in this dataset, which had at least 80% power to detect SNPs whose MAF is greater than 15% and have an effect size greater than two. A few of the SNPs have very low MAF, and some may be associated but with a small effect size and will need to be investigated in larger cohorts.</p><p id="P26">There are a few limitations in this study. First, the discovery cohort was treated mainly with brachytherapy whereas the replication cohort was largely treated with EBRT and had lower mean BED (<a href="/pmc/articles/PMC3787843/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>). While treatment type or dose would not confound SNP association with rectal bleeding, these variables could act as effect modifiers, explaining in part the difference in magnitude of the odds ratios between the discovery and replication cohorts. Despite these treatment differences between cohorts, we were able to identify associated SNPs, suggesting there may be genetic predictors that are non-specific for treatment modality. Another limitation is that different scoring systems were used to assess rectal bleeding, possibly introducing some misclassification bias. However, we believe the scoring systems can be harmonized and that we were able to achieve consistency across cohorts. Finally, while the rectal V100 was not significantly different between cases and controls in the discovery cohort, this data was not available for patients in the replication cohort. It will be important to investigate the possible interaction between rectal V100 and SNPs so that predictive models can include both genetic and non-genetic factors.</p><p id="P27" class="p p-last">Using a GWAS approach, we identified a locus reaching genome-wide significance for association with rectal bleeding. Additional validation studies are needed to both confirm this finding and to determine whether the other SNPs with marginally significant p-values are in fact associated with late rectal bleeding. Additional studies with larger sample sizes may also uncover additional variants with smaller effect sizes. The current study is an important step in the process of identifying predictors of radiotherapy toxicity that could be used to better tailor therapy to each individual patient.</p></div><div id="S12" class="tsec sec"><a id="supplementary-material-sec"></a><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S12title">Supplementary Material</h2><!--/article/body/sec/--><div class="sec suppmat" id="SD1"><h4>01</h4><p id="P28">Supplementary Figure 1. Principle components analysis. A. 11 HapMap reference populations. B. HapMap populations with prostate RT patients. Abbreviations: YRI, Yoruban in Ibadan, Nigeria; LWK, Luhya in Webuye, Kenya; MKK, Maasai in Kinyawa, Kenya; ASW; African ancestry in Southwest USA; CEU, Utah residents with Northern and Western European ancestry; TSI, Tuscan in Italy; GIH, Gujarati Indians in Houston, Texas; MEX, Mexican ancestry in Los Angeles, California; CHB, Han Chinese in Beijing, China; CHD, Chinese in Metropolitan Denver, Colorado; JPT, Japanese in Tokyo, Japan.</p><div class="sup-box half_rhythm" id="d36e639"><a href="/pmc/articles/PMC3787843/bin/NIHMS487926-supplement-01.png" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(117K, png)</sup></div></div><div class="sec suppmat" id="SD2"><h4>02</h4><p id="P29">Supplementary Figure 2. Q-Q plot from logistic regression adjusted for the first five principle components.</p><div class="sup-box half_rhythm" id="d36e646"><a href="/pmc/articles/PMC3787843/bin/NIHMS487926-supplement-02.tif" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(1.2M, tif)</sup></div></div><div class="sec suppmat" id="SD3"><h4>03</h4><div class="sup-box half_rhythm" id="d36e650"><a href="/pmc/articles/PMC3787843/bin/NIHMS487926-supplement-03.doc" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(50K, doc)</sup></div></div><div class="sec suppmat" id="SD4"><h4>04</h4><div class="sup-box half_rhythm" id="d36e654"><a href="/pmc/articles/PMC3787843/bin/NIHMS487926-supplement-04.docx" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(12K, docx)</sup></div></div></div><div id="S13" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S13title">Acknowledgments</h2><div class="sec"><p id="__p2">This research was supported by grants RSGT-05-200-01-CCE from the American Cancer Society (to BSR), PC074201 from the Department of Defense and 1R01CA134444 from the National Institutes of Health (to BSR and HO), FIS PI10/00164 from the Instituto de Salud Carlos III and FEDER 2007–2013 from Fondo Europeo de Desarrollo Regional (CHUS cohort), and 103.0393.71760001404 through the Alberta Cancer Board Research Initiative Program (CCI cohort).</p></div></div><div id="idm139767455097168" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139767455097168title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="FN3"><sup>*</sup>Collaboration developed under the framework of the Radiogenomics Consortium</p><p class="fn sec" id="FN4"> </p><p id="__p4" class="p p-first"><strong>Conflict of Interest</strong></p><p id="__p5" class="p p-last">N.N. Stone is a consultant for Amgen, Ferring, Janssen, Diversified Conference Management, Prologics LLC, and Nihon MediPhysics. R.G. Stock has received payment for lectures and preparation of educational materials from Bard. All other authors report no conflicts of interest.</p><p></p><p class="fn sec" id="FN5"></p><p id="__p6" class="p p-first-last"><strong>Publisher's Disclaimer: </strong>This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.</p><p></p></div></div><div id="idm139767458337152" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139767458337152title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="R1">1. <span class="element-citation">Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. <span><span class="ref-journal">Int J Cancer. </span>2010;<span class="ref-vol">127</span>:2893–2917.</span> [<a href="/pubmed/21351269" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Cancer&amp;title=Estimates+of+worldwide+burden+of+cancer+in+2008:+GLOBOCAN+2008&amp;author=J+Ferlay&amp;author=HR+Shin&amp;author=F+Bray&amp;author=D+Forman&amp;author=C+Mathers&amp;volume=127&amp;publication_year=2010&amp;pages=2893-2917&amp;pmid=21351269&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R2">2. <span class="element-citation">Grimm P, Billiet I, Bostwick D, et al.  Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group. <span><span class="ref-journal">BJU Int. </span>2012;<span class="ref-vol">109 </span>(Suppl 1):22–29.</span> [<a href="/pubmed/22239226" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BJU+Int&amp;title=Comparative+analysis+of+prostate-specific+antigen+free+survival+outcomes+for+patients+with+low,+intermediate+and+high+risk+prostate+cancer+treatment+by+radical+therapy.+Results+from+the+Prostate+Cancer+Results+Study+Group&amp;author=P+Grimm&amp;author=I+Billiet&amp;author=D+Bostwick&amp;volume=109+&amp;issue=Suppl+1&amp;publication_year=2012&amp;pages=22-29&amp;pmid=22239226&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R3">3. <span class="element-citation">Barnett GC, De Meerleer G, Gulliford SL, Sydes MR, Elliott RM, Dearnaley DP. The impact of clinical factors on the development of late radiation toxicity: results from the Medical Research Council RT01 trial (ISRCTN47772397) <span><span class="ref-journal">Clin Oncol (R Coll Radiol) </span>2011;<span class="ref-vol">23</span>:613–624.</span> [<a href="/pubmed/21470834" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Oncol+(R+Coll+Radiol)&amp;title=The+impact+of+clinical+factors+on+the+development+of+late+radiation+toxicity:+results+from+the+Medical+Research+Council+RT01+trial+(ISRCTN47772397)&amp;author=GC+Barnett&amp;author=G+De+Meerleer&amp;author=SL+Gulliford&amp;author=MR+Sydes&amp;author=RM+Elliott&amp;volume=23&amp;publication_year=2011&amp;pages=613-624&amp;pmid=21470834&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R4">4. <span class="element-citation">Bentzen SM, Overgaard J. Patient-to-Patient Variability in the Expression of Radiation-Induced Normal Tissue Injury. <span><span class="ref-journal">Semin Radiat Oncol. </span>1994;<span class="ref-vol">4</span>:68–80.</span> [<a href="/pubmed/10717093" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Semin+Radiat+Oncol&amp;title=Patient-to-Patient+Variability+in+the+Expression+of+Radiation-Induced+Normal+Tissue+Injury&amp;author=SM+Bentzen&amp;author=J+Overgaard&amp;volume=4&amp;publication_year=1994&amp;pages=68-80&amp;pmid=10717093&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R5">5. <span class="element-citation">Emami B, Lyman J, Brown A, et al.  Tolerance of normal tissue to therapeutic irradiation. <span><span class="ref-journal">Int J Radiat Oncol Biol Phys. </span>1991;<span class="ref-vol">21</span>:109–122.</span> [<a href="/pubmed/2032882" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Radiat+Oncol+Biol+Phys&amp;title=Tolerance+of+normal+tissue+to+therapeutic+irradiation&amp;author=B+Emami&amp;author=J+Lyman&amp;author=A+Brown&amp;volume=21&amp;publication_year=1991&amp;pages=109-122&amp;pmid=2032882&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R6">6. <span class="element-citation">Rosenstein BS. Identification of SNPs associated with susceptibility for development of adverse reactions to radiotherapy. <span><span class="ref-journal">Pharmacogenomics. </span>2011;<span class="ref-vol">12</span>:267–275.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3128821/">PMC free article</a>]</span> [<a href="/pubmed/21332318" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacogenomics&amp;title=Identification+of+SNPs+associated+with+susceptibility+for+development+of+adverse+reactions+to+radiotherapy&amp;author=BS+Rosenstein&amp;volume=12&amp;publication_year=2011&amp;pages=267-275&amp;pmid=21332318&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R7">7. <span class="element-citation">Barnett GC, Coles CE, Elliott RM, et al.  Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study. <span><span class="ref-journal">Lancet Oncol. </span>2012;<span class="ref-vol">13</span>:65–77.</span> [<a href="/pubmed/22169268" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet+Oncol&amp;title=Independent+validation+of+genes+and+polymorphisms+reported+to+be+associated+with+radiation+toxicity:+a+prospective+analysis+study&amp;author=GC+Barnett&amp;author=CE+Coles&amp;author=RM+Elliott&amp;volume=13&amp;publication_year=2012&amp;pages=65-77&amp;pmid=22169268&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R8">8. <span class="element-citation">Stock RG, Stone NN, Wesson MF, DeWyngaert JK. A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation. <span><span class="ref-journal">Int J Radiat Oncol Biol Phys. </span>1995;<span class="ref-vol">32</span>:219–225.</span> [<a href="/pubmed/7721619" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Radiat+Oncol+Biol+Phys&amp;title=A+modified+technique+allowing+interactive+ultrasound-guided+three-dimensional+transperineal+prostate+implantation&amp;author=RG+Stock&amp;author=NN+Stone&amp;author=MF+Wesson&amp;author=JK+DeWyngaert&amp;volume=32&amp;publication_year=1995&amp;pages=219-225&amp;pmid=7721619&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R9">9. <span class="element-citation">Stone NN, Hong S, Lo YC, Howard V, Stock RG. Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy. <span><span class="ref-journal">Brachytherapy. </span>2003;<span class="ref-vol">2</span>:17–25.</span> [<a href="/pubmed/15062159" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Brachytherapy&amp;title=Comparison+of+intraoperative+dosimetric+implant+representation+with+postimplant+dosimetry+in+patients+receiving+prostate+brachytherapy&amp;author=NN+Stone&amp;author=S+Hong&amp;author=YC+Lo&amp;author=V+Howard&amp;author=RG+Stock&amp;volume=2&amp;publication_year=2003&amp;pages=17-25&amp;pmid=15062159&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R10">10. <span class="element-citation">Fachal L, Gomez-Caamano A, Sanchez-Garcia M, et al.  TGFbeta1 SNPs and radio-induced toxicity in prostate cancer patients. <span><span class="ref-journal">Radiother Oncol. </span>2012;<span class="ref-vol">103</span>:206–209.</span> [<a href="/pubmed/22385796" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Radiother+Oncol&amp;title=TGFbeta1+SNPs+and+radio-induced+toxicity+in+prostate+cancer+patients&amp;author=L+Fachal&amp;author=A+Gomez-Caamano&amp;author=M+Sanchez-Garcia&amp;volume=103&amp;publication_year=2012&amp;pages=206-209&amp;pmid=22385796&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R11">11. <span class="element-citation">Stock RG, Stone NN, Cesaretti JA, Rosenstein BS. Biologically effective dose values for prostate brachytherapy: effects on PSA failure and posttreatment biopsy results. <span><span class="ref-journal">Int J Radiat Oncol Biol Phys. </span>2006;<span class="ref-vol">64</span>:527–533.</span> [<a href="/pubmed/16242258" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Radiat+Oncol+Biol+Phys&amp;title=Biologically+effective+dose+values+for+prostate+brachytherapy:+effects+on+PSA+failure+and+posttreatment+biopsy+results&amp;author=RG+Stock&amp;author=NN+Stone&amp;author=JA+Cesaretti&amp;author=BS+Rosenstein&amp;volume=64&amp;publication_year=2006&amp;pages=527-533&amp;pmid=16242258&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R12">12. <span class="element-citation">Purcell S, Neale B, Todd-Brown K, et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. <span><span class="ref-journal">Am J Hum Genet. </span>2007;<span class="ref-vol">81</span>:559–575.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1950838/">PMC free article</a>]</span> [<a href="/pubmed/17701901" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hum+Genet&amp;title=PLINK:+a+tool+set+for+whole-genome+association+and+population-based+linkage+analyses&amp;author=S+Purcell&amp;author=B+Neale&amp;author=K+Todd-Brown&amp;volume=81&amp;publication_year=2007&amp;pages=559-575&amp;pmid=17701901&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R13">13. <span class="element-citation">Consortium IH. The International HapMap Project. <span><span class="ref-journal">Nature. </span>2003;<span class="ref-vol">426</span>:789–796.</span> [<a href="/pubmed/14685227" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=The+International+HapMap+Project&amp;author=IH+Consortium&amp;volume=426&amp;publication_year=2003&amp;pages=789-796&amp;pmid=14685227&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R14">14. <span class="element-citation">Team RDC. <span class="ref-journal">R: A language and environment for statistical computing R Foundation for Statistical Computing.</span> 2.13.1. Vienna, Austria: 2011.  <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=R:+A+language+and+environment+for+statistical+computing+R+Foundation+for+Statistical+Computing&amp;publication_year=2011&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R15">15. <span class="element-citation">Ge D.  In: <span class="ref-journal">MetaP: a program to combine P values.</span> Ge D, editor. 2009.  <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=MetaP:+a+program+to+combine+P+values&amp;author=D+Ge&amp;publication_year=2009&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R16">16. <span class="element-citation">Kerns SL, Stock R, Stone N, et al.  A 2-Stage Genome-Wide Association Study to Identify Single Nucleotide Polymorphisms Associated With Development of Erectile Dysfunction Following Radiation Therapy for Prostate Cancer. <span><span class="ref-journal">International journal of radiation oncology, biology, physics. </span>2012</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3616619/">PMC free article</a>]</span> [<a href="/pubmed/23021708" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=International+journal+of+radiation+oncology,+biology,+physics&amp;title=A+2-Stage+Genome-Wide+Association+Study+to+Identify+Single+Nucleotide+Polymorphisms+Associated+With+Development+of+Erectile+Dysfunction+Following+Radiation+Therapy+for+Prostate+Cancer&amp;author=SL+Kerns&amp;author=R+Stock&amp;author=N+Stone&amp;publication_year=2012&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R17">17. <span class="element-citation">Heublein S, Kazi S, Ogmundsdottir MH, et al.  Proton-assisted amino-acid transporters are conserved regulators of proliferation and amino-acid-dependent mTORC1 activation. <span><span class="ref-journal">Oncogene. </span>2010;<span class="ref-vol">29</span>:4068–4079.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3018277/">PMC free article</a>]</span> [<a href="/pubmed/20498635" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Proton-assisted+amino-acid+transporters+are+conserved+regulators+of+proliferation+and+amino-acid-dependent+mTORC1+activation&amp;author=S+Heublein&amp;author=S+Kazi&amp;author=MH+Ogmundsdottir&amp;volume=29&amp;publication_year=2010&amp;pages=4068-4079&amp;pmid=20498635&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R18">18. <span class="element-citation">Schiewer MJ, Den R, Hoang DT, et al.  mTOR is a selective effector of the radiation therapy response in androgen receptor-positive prostate cancer. <span><span class="ref-journal">Endocr Relat Cancer. </span>2012;<span class="ref-vol">19</span>:1–12.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3253653/">PMC free article</a>]</span> [<a href="/pubmed/21903859" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Endocr+Relat+Cancer&amp;title=mTOR+is+a+selective+effector+of+the+radiation+therapy+response+in+androgen+receptor-positive+prostate+cancer&amp;author=MJ+Schiewer&amp;author=R+Den&amp;author=DT+Hoang&amp;volume=19&amp;publication_year=2012&amp;pages=1-12&amp;pmid=21903859&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R19">19. <span class="element-citation">Ausborn NL, Le QT, Bradley JD, et al.  Molecular profiling to optimize treatment in non-small cell lung cancer: a review of potential molecular targets for radiation therapy by the translational research program of the radiation therapy oncology group. <span><span class="ref-journal">Int J Radiat Oncol Biol Phys. </span>2012;<span class="ref-vol">83</span>:e453–464.</span> [<a href="/pubmed/22520478" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Radiat+Oncol+Biol+Phys&amp;title=Molecular+profiling+to+optimize+treatment+in+non-small+cell+lung+cancer:+a+review+of+potential+molecular+targets+for+radiation+therapy+by+the+translational+research+program+of+the+radiation+therapy+oncology+group&amp;author=NL+Ausborn&amp;author=QT+Le&amp;author=JD+Bradley&amp;volume=83&amp;publication_year=2012&amp;pages=e453-464&amp;pmid=22520478&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R20">20. <span class="element-citation">Pati D, Keller C, Groudine M, Plon SE. Reconstitution of a MEC1-independent checkpoint in yeast by expression of a novel human fork head cDNA. <span><span class="ref-journal">Mol Cell Biol. </span>1997;<span class="ref-vol">17</span>:3037–3046.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC232156/">PMC free article</a>]</span> [<a href="/pubmed/9154802" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cell+Biol&amp;title=Reconstitution+of+a+MEC1-independent+checkpoint+in+yeast+by+expression+of+a+novel+human+fork+head+cDNA&amp;author=D+Pati&amp;author=C+Keller&amp;author=M+Groudine&amp;author=SE+Plon&amp;volume=17&amp;publication_year=1997&amp;pages=3037-3046&amp;pmid=9154802&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3787843&amp;issue-id=228042&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="#ui-ncbiinpagenav-heading-3">Associated Data</a></li><li><a href="#idm139767456599776title">Abstract</a></li><li><a href="#S5title">Introduction</a></li><li><a href="#S6title">Materials and Methods</a></li><li><a href="#S10title">Results</a></li><li><a href="#S11title">Discussion</a></li><li><a href="#S12title">Supplementary Material</a></li><li><a href="#S13title">Acknowledgments</a></li><li><a href="#idm139767455097168title">Footnotes</a></li><li><a href="#idm139767458337152title">References</a></li></ul></div></div><!--post-content--></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC3787843/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC3787843/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC3787843/pdf/nihms487926.pdf">PDF (50K)</a></li> | <li><a href="#" data-citationid="PMC3787843" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3787843%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3787843%2F&amp;text=Genome-wide%20association%20study%20identifies%20a%20region%20on%20chromosome%2011q14.3%20associated%20with%20late%20rectal%20bleeding%20following%20radiation%20therapy%20for%20prostate%20cancer" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3787843%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="23719583" data-aiid="3787843" data-aid="3787843" data-iid="228042" data-domainid="319" data-domain="nihpa" data-accid="PMC3787843" data-md5="a117837d1df3c7979df0d7a67e7715dd"><img src="/portal/portal3rc.fcgi/4018218/img/3631476" alt="Loading..." align="absmiddle"> Loading portlets...</div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-20T10:55:36-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal104&amp;ncbi_phid=CE8B98DBDD560AC1000000000102009C&amp;ncbi_session=CE8C6010DD4F8B31_0740SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3787843%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 68.1px; left: 377.2px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=nihpa&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC3787843/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C6010DD4F8B31_0740SID /projects/PMC/PMCViewer@4.46 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div></body></html>